Stock Events

Stock Events

Amryt Pharma 

GBX143
8
+GBX0+0% Monday 17:35

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

3NovExpected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-21.31
-15.11
-8.91
-2.71
Expected EPS
N/A
Actual EPS
-4.7244

Financials

0.62%Profit Margin
Profitable
2016
2017
2018
2019
2020
2021
16.3BRevenue
101.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AMYT.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals focuses on developing treatments for cystic fibrosis and other diseases, overlapping with Amryt's focus on rare diseases.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical develops enzyme replacement therapies similar to Amryt's approach in treating rare genetic disorders.
Sarepta Therapeutics
SRPT
Mkt Cap2.51B
Sarepta Therapeutics focuses on the discovery and development of RNA-targeted therapeutics, competing in the rare disease sector.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is involved in developing and commercializing products for treating rare diseases, similar to Amryt's focus.
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Ionis Pharmaceuticals specializes in RNA-targeted drug discovery, which competes with Amryt's treatments for rare diseases.
Galapagos NV
GLPG
Mkt Cap2.09B
Galapagos NV focuses on developing novel modes of action, including treatments for cystic fibrosis, a market Amryt is also interested in.
Natera
NTRA
Mkt Cap27.3B
Natera specializes in genetic testing and diagnostics, which complements and competes with Amryt's approach to personalized medicine in rare diseases.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is engaged in gene editing technologies, which could potentially compete with Amryt's treatments for genetic disorders.

About

Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Show more...
CEO
Dr. Joseph A. Wiley
Employees
182
Country
GB
ISIN
GB00BKLTQ412

Listings

0 Comments

Share your thoughts

FAQ

What is Amryt Pharma stock price today?▼
The current price of AMYT.LSE is GBX143 GBX — it has increased by +0% in the past 24 hours. Watch Amryt Pharma stock price performance more closely on the chart.
What is Amryt Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Amryt Pharma stocks are traded under the ticker AMYT.LSE.
What were Amryt Pharma earnings last quarter?▼
AMYT.LSE earnings for the last quarter are -4.72 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Amryt Pharma revenue for the last year?▼
Amryt Pharma revenue for the last year amounts to 16.3B GBX.
What is Amryt Pharma net income for the last year?▼
AMYT.LSE net income for the last year is 101.12M GBX.
How many employees does Amryt Pharma have?▼
As of April 05, 2026, the company has 182 employees.
In which sector is Amryt Pharma located?▼
Amryt Pharma operates in the Healthcare sector.
When did Amryt Pharma complete a stock split?▼
Amryt Pharma has not had any recent stock splits.
Where is Amryt Pharma headquartered?▼
Amryt Pharma is headquartered in Dublin, GB.